Sensei Biotherapeutics Inc — Quarterly Financial Statistics (NASDAQ:SNSE) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -5.79 M-7.09 M-5.91 M-3.59 M-3.86 M -20.45 M Cash from investing activities -3.15 M7.19 M8.76 M1.74 M2.08 M 19.77 M Cash from financing activities -194 K-214 K-168 K-152 K-111 K -645 K Free cash flow -5.79 M-7.09 M-5.92 M-3.59 M-3.86 M -20.47 M

News

Sensei Biotherapeutics grants stock options to 17 new employees

Sensei Biotherapeutics, Inc. (SNSE) Faeth Therapeutics, Inc. - M&A Call - Slideshow (NASDAQ:SNSE) 2026-02-20

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.26%

Sensei Biotherapeutics stock soars after Faeth Therapeutics acquisition

Sensei acquires Faeth, raises $200 million for cancer drug pipeline

Why Is Sensei Biotherapeutics Stock Skyrocketing Wednesday? - Sensei Biotherapeutics (NASDAQ:SNSE)

Egle Therapeutics appoints John Celebi as CEO to advance autoimmune pipeline

What Sparked Sensei Biotherapeutics (SNSE) Stock's Nearly 63% After‑Hours Jump? - Sensei Biotherapeutics (NASDAQ:SNSE)

Sensei Biotherapeutics stock rating downgraded as company halts key drug

Sensei Biotherapeutics stock rises after announcing strategic review

Sensei Biotherapeutics discontinues cancer drug, explores alternatives

Sensei Biotherapeutics stock falls after Phase 1/2 trial results